-
Voliotis Dimitris
2023/03/21
SVP, Clinical Development
119563
-30601
2023-03-21
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/03/20
1450000
-500000
2023-03-20
0001725160
0001725160
950000
-
Epperly Melissa B,
2023/03/19
Chief Financial Officer
459293
-94611
2023-03-19
0001725160
0001725160
364682
-
Voliotis Dimitris
2023/03/18
SVP, Clinical Development
119563
-30601
2023-03-18
0001725160
0001725160
88962
-
Voliotis Dimitris
2023/03/17
SVP, Clinical Development
119563
-30601
2023-03-17
0001725160
0001725160
88962
-
Epperly Melissa B,
2023/03/16
Chief Financial Officer
459293
-94611
2023-03-16
0001725160
0001725160
364682
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/03/15
1450000
-500000
2023-03-15
0001725160
0001725160
950000
-
Viking Global Opportunities GP LLC
2023/03/14
1450000
-500000
2023-03-14
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/03/13
SVP, Clinical Development
119563
-30601
2023-03-13
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/03/12
1450000
-500000
2023-03-12
0001725160
0001725160
950000